Market Research Logo

Healthcare Associated Infection (HAI) Control Markets, Forecasts to 2020: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments

Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments

Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may occur in a postoperative wound or as a complication unrelated to the disease or condition. This report, Healthcare-Associated Infection (HAI) Control Markets: focuses on the market opportunities for companies that can assist hospitals and other healthcare facilities with important HAI mitigation tasks including: preventing, testing and treating infections in the healthcare environment.

The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. Worldwide, the rate of nosocomial infections is between 3.5% and 12% of admissions in developed regions. This is driving the demand for products and services. The report focuses on three areas: Prevention, Testing and Treatment and will provide a market analysis for each of the important segments:

  • Disinfection
  • Wide-Area Sterilization
  • Device Sterilization
  • HAI Testing – C.diff
  • HAI Testing – MRSA
  • HAI Testing - Others
  • HAI Treatment –Antibiotic Products
For each larger segment (Prevention, Testing and Treatment) company market share is provided. For each larger segment (Prevention, Testing, Treatment) regional market share is provided for the following countries and regions: US, Europe, Eastern Europe, Japan, Canada, China, Mexico, Brazil, Africa, India, Rest of World.

Market analysis in this report considers primarily the epidemiological considerations and the size patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the majormarkets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital and primary care environment in order to construct a picture of the infection prevention, testing and treatment needs.

As part of the report’s coverage, the following trends are discussed:
  • Nosocomial Infection Statistics
  • Affordable Care Act (ACA) Funding
  • Populations at Risk for Infection
  • Infection Risk Assessments by Hospital Department
  • Increased Hospital Length of Stay for HAIs
  • International Trends in Nursing Facilities
  • U.S. Government's National Plan to Prevent Healthcare
  • Government Funding for HAI Prevention Infrastructure Activities
  • Israel Reduction in HAIs
  • Arizona Prevention Study
  • Connecticut Funding for HAI Prevention and Reporting
  • Pennsylvania Study of HAI Admissions and Readmissions
  • Infections and Drug Resistance
  • Screening Trends
  • Trends in Partnerships and Alliances
  • Current Burden of HAI Statistics
The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers. The following companies are profiled in this report:
  • Advanced Sterilization Products
  • Becton, Dickinson and Company
  • Belimed
  • bioMerieux
  • Cantel
  • Cepheid
  • Getinge Group
  • Kimberly-Clark
  • Merck & Co
  • Nordion
  • Pfizer
  • Roche
  • Sakura Seiki
  • Steris
  • Tso3


  • Executive Summary
    • OVERVIEW
      • The Nosocomial Infection
        • Table Frequency of the Most Common Nosocomial Infections
    • SCOPE AND METHODOLOGY
    • TOTAL SIZE AND GROWTH OF THE MARKET
      • Table The World Market for Healthcare Infection Control 2008-2020
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
  • Introduction and Industry Trends
    • OVERVIEW
      • Introduction to Pathogens
      • Classification of Antibacterial Organisms
      • Patient Risk Factors
      • General Infection Statistics
      • Populations at Risk for Infection
        • Table World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region, 2012-2013 Data
    • DEMOGRAPHICS OF THE WORLD
      • Table World Population by Selected Geographical Region, 2010 - 2050
      • Table Estimated World Population by Age and Geographical Region, 2013
      • Life Expectancy
        • Table Average Life Expectancy in Years by Country 1980 and 2012
      • Nosocomial Infection Statistics
      • Common Hospital (nosocomial) Infections
    • INFECTION RISK ASSESSMENTS BY HOSPITAL DEPARTMENT
      • Burn Units
        • Table Burn Statistics
      • Intensive Care Units
      • Emergency Departments
      • Hospital Length of Stay
        • Table U.S. Hospital Length of Stay, Average by Age Group
        • Table Average International Length of Stay, by Country 2010
      • Extended Stay Environments
        • Table U.S. Nursing Homes, Beds, Residents and Occupancy Rate, 2011
        • Table Estimated Nursing Service Establishments and Care Centers by Country
    • ECONOMIC TRENDS
      • Table Total Healthcare Expenditures as a Percent of GDP by Country 2010 and 2012
      • Comparison Between Healthcare Spending and Real Health Outcomes
        • Table Healthcare Spending, Obesity and Life Expectancy, 2012
    • U.S. GOVERNMENT'S NATIONAL PLAN TO PREVENT HEALTHCARE ASSOCIATED INFECTIONS (HAIS)
      • Steering Committee
      • The American Recovery and Reinvestment Act of 2009
      • Affordable Care Act (ACA) Funding
      • Government Funding for HAI Prevention Infrastructure Activities
        • Table U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013
      • National Healthcare Safety Network
      • U.S. Statewide Standardized Infection Ratio
        • Table U.S. States Hospital Acquired Infection Standardized Infection Ratio (SIR) 2010, 2011 and 2012
    • REDUCTION IN HOSPITAL ACQUIRED INFECTIONS
      • Reduction in Infections in Israel
      • Burden of Hospital Acquired Infections
      • Healthcare Infection Surveillance Process
    • CASE STUDIES
      • Arizona Prevention Study
      • Connecticut Funding for HAI Prevention and Reporting
      • Pennsylvania Study of HAI Admissions and Readmissions
        • Table Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2010
        • Table Pennsylvania State Analysis of HAIs, 2010
    • INFECTIONS AND DRUG RESISTANCE
      • Easing Approvals of Antibiotics
      • Causes of Drug Resistance
      • Drug Resistance in Select Populations
      • Measures for Reducing Resistance
      • Screening Hospitalized patients
    • PHARMACEUTICAL MANUFACTURER AND MARKETER TRENDS
      • Trends in Partnerships and Alliances
      • Developers Trends
  • Infection Prevention
    • OVERVIEW
      • Methods of Transmission
      • High-Risk Facilities or Departments
      • Technology Overview
      • Sterilization vs. Disinfection
      • Equipment and Solutions
      • Heat/Steam Sterilization
      • Chemical Sterilization
        • Table Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants1 or as High-Level Disinfectants
        • Table Comparison of the Characteristics of Selected Chemicals Used as High-Level Disinfectants or Chemical Sterilants
      • Mid-Level Disinfectants
        • Table Comparison of the Characteristics of Selected Hospital Disinfectants for General Disinfection of Environmental Surfaces
      • Radiation Sterilization
      • Sterilization and Disinfection Verification Systems
        • Table New Developments, Healthcare Infection Prevention
    • MARKET OVERVIEW
      • Table The World Market for Healthcare Infection Prevention (Sterilization/Disinfection Segment) 2008-2020
      • Healthcare Infection Prevention Market by Geographical Region
        • Table The World Market for Healthcare Infection Prevention (Sterilization/Disinfection Segment) Estimated Products Sales by Primary Geographic Region 2008-2020
    • COMPETITIVE ANALYSIS
      • Table The World Market for Healthcare Infection Prevention (Sterilization/Disinfection Segment) Leading Suppliers' Shares Estimates for 2014
  • Infection Testing
    • OVERVIEW
      • Drug-Resistance/Susceptibility Testing
      • Genotypic Methods
    • SPECIFIC SERIOUS HEALTHCARE INFECTION TESTING
      • Acinetobacter Baumannii
      • Clostridium Difficile
      • Hospital-Acquired Pneumonia
      • Pseudomonas Aeruginosa
      • Staphylococcus Aureus
      • Tuberculosis
      • Urinary Tract Infections
      • Vancomycin-resistant Enterococcus
      • Ventilator-Associated Pneumonia
        • Table Recent Approvals for Detecting Serious Healthcare Infections
    • NEW DEVELOPMENTS
      • Table New Developments, Healthcare Infection Testing, as of April 2014
    • MARKET OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table The World Market for Healthcare Infection Testing/Diagnostics 2008-2020
      • Healthcare Infection Testing Market by Geographical Region
        • Table The World Market for Healthcare Infection Testing/Diagnostics Estimated Products Sales by Primary Geographic Region 2008-2020
    • COMPETITIVE ANALYSIS
      • Table The World Market for Healthcare Infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2014
  • Infection Treatment
    • OVERVIEW
      • Table Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
      • Principles of Anti-bacterial Therapy
    • CLASSIFICATIONS OF ANTIBACTERIAL PRODUCTS
      • Carbapenems
      • Cephalosporins
      • Macrolides
      • Penicillins
      • Quinolones
      • Sulfonamides
      • Tetracyclines
        • Table Antibiotics with Difficult Penetration
    • TREATMENT GUIDELINES
      • Clostridium Difficile
      • Gastroenteritis
      • Hospital-Acquired Pneumonia
      • Ventilator-associated Pneumonia
      • Pseudomonas Aeruginosa
      • Staphylococcus Aureus
      • Stenotrophomonas maltophilia
      • Tuberculosis
      • Urinary Tract Infections
    • LEADING PRODUCTS
      • Table Annual Sales of Select Antibacterial Products 2013
    • NEW DEVELOPMENTS
      • Table New Developments, Healthcare Infection Treatments, as of March 2014
    • TOTAL MARKET SIZE AND FORECAST
      • Table The World Market for Healthcare Infection Treatment 2008-2020
      • Healthcare Infection Treatment Market by Geographical Region
        • Table The World Market for Healthcare Infection Treatment Estimated Products Sales by Primary Geographic Region 2008-2020
    • COMPETITIVE ANALYSIS
      • Table The World Market for Healthcare Infection Treatment Leading Suppliers' Shares Estimates for 2014
  • Market Opportunities for Healthcare Infection Control
    • MARKET CONSIDERATIONS
    • MARKET OVERVIEW
      • Table The World Market for Healthcare Infection Control 2008-2020
      • Healthcare Infection Control Market by Geographical Region
        • Table The World Market for Healthcare Infection Control Estimated Products Sales by Primary Geographic Region 2008-2020
      • Developed and Emerging Market Analysis
  • Company Profiles
    • INTRODUCTION
    • ADVANCED STERILIZATION PRODUCTS
      • Company Performance
    • BECTON, DICKINSON AND COMPANY
      • Company Performance
    • BELIMED
      • Company Performance
    • BIOMERIEUX
      • Company Performance
    • CANTEL
      • Company Performance
    • CEPHEID
      • Company Performance
    • GETINGE GROUP
      • Company Performance
    • KIMBERLY-CLARK
      • Company Performance
    • MERCK & CO.
      • Company Performance
    • NORDION
      • Company Performance
    • PFIZER
      • Company Performance
    • ROCHE
      • Company Performance
    • SAKURA SEIKI
    • STERIS
      • Company Performance
    • TSO3
      • Company Performance
  • List of Major Providers

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report